Exploring the Role of DDIT3 in Tumorigenesis and Its Potential as a Target for Novel Cancer Therapies

Cancer continues to be the leading cause of death globally, with mounting evidence associating cellular stress with tumor initiation, progression, and therapeutic resistance. DNA damage-inducible transcript 3 (DDIT3), a key stress-responsive transcription factor, plays a central role in cellular stress responses by regulating apoptosis, cell survival, and the tumor microenvironment. Although DDIT3 has been extensively studied in neurodegenerative and metabolic diseases, its dual role in cancer has only recently begun to emerge. This review systematically explores the intricate functions of DDIT3 in cancer biology, emphasizing its involvement in endoplasmic reticulum (ER) stress, apoptosis regulation, and modulation of the tumor microenvironment. We investigate how DDIT3 interacts with key signaling pathways and its impact on cellular stress responses, such as autophagy and macrophage recruitment within the tumor microenvironment. Furthermore, we evaluate the therapeutic potential of targeting DDIT3 through clinical and preclinical drug studies, concentrating on compounds that enhance its pro-apoptotic functions or inhibit its cancer-promoting activities. This review seeks to provide a comprehensive understanding of DDIT3′s role in tumors, offering insights into future therapeutic strategies targeting this stress-related protein in oncology.

Authors

Institutions

Publication Details

Journal
Biophysica
Published
2026-11-13
DOI
https://doi.org/10.3390/biophysica6060114
Primary Topic
Endoplasmic Reticulum Stress and Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Exploring the Role of DDIT3 in Tumorigenesis and Its Potential as a Target for Novel Cancer Therapies

Guoqing Huang, Dandan Wang
1 links
Biophysica
Endoplasmic Reticulum Stress and Disease
article

Exploring the Role of DDIT3 in Tumorigenesis and Its Potential as a Target for Novel Cancer Therapies

Guoqing Huang, Dandan Wang
article en

Abstract

Cancer continues to be the leading cause of death globally, with mounting evidence associating cellular stress with tumor initiation, progression, and therapeutic resistance. DNA damage-inducible transcript 3 (DDIT3), a key stress-responsive transcription factor, plays a central role in cellular stress responses by regulating apoptosis, cell survival, and the tumor microenvironment. Although DDIT3 has been extensively studied in neurodegenerative and metabolic diseases, its dual role in cancer has only recently begun to emerge. This review systematically explores the intricate functions of DDIT3 in cancer biology, emphasizing its involvement in endoplasmic reticulum (ER) stress, apoptosis regulation, and modulation of the tumor microenvironment. We investigate how DDIT3 interacts with key signaling pathways and its impact on cellular stress responses, such as autophagy and macrophage recruitment within the tumor microenvironment. Furthermore, we evaluate the therapeutic potential of targeting DDIT3 through clinical and preclinical drug studies, concentrating on compounds that enhance its pro-apoptotic functions or inhibit its cancer-promoting activities. This review seeks to provide a comprehensive understanding of DDIT3′s role in tumors, offering insights into future therapeutic strategies targeting this stress-related protein in oncology.

BiophysicaVol. 6(6)
Heilongjiang Academy of Sciences (CN)
Good health and well-being
Endoplasmic Reticulum Stress and Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon